Articles with public access mandates - Ashley Bush - Alzheimers's UKLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallNHMRCARCNIHNSFCCIHREuropean CommissionAlzheimers's UKDoDMRCDFGKnut and Alice Wallenberg FoundationSwedish Research CouncilParkinson's UKGovernment of SpainMichael J Fox FoundationINSERMDSTMarianne and Marcus Wallenberg FoundationNSFDBTBMBFMedical Research Future Fund, AustraliaDOEAHAFWFAcademy of FinlandFORTENIHRGovernment of ItalyV Foundation, USAAIRC Foundation for Cancer Research in ItalyFlorida Department of Health, USALeducq Foundation, USAHFSP
Not available based on mandate: 4
Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention
A Tsatsanis, BX Wong, AP Gunn, S Ayton, AI Bush, D Devos, JA Duce
Molecular psychiatry 25 (9), 1958-1966, 2020
Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age
S Ayton, S Janelidze, B Roberts, S Palmqvist, P Kalinowski, I Diouf, ...
Progress in Neurobiology 198, 101904, 2021
The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related Disorders
S Ayton, S Hall, S Janelidze, P Kalinowski, S Palmqvist, AA Belaidi, ...
Movement Disorders 37 (5), 993-1003, 2022
Iron as a therapeutic target for Parkinson's disease
JA Duce, O Rascol, JC Devedjan, D Berg, D Dexter, ZI Cabantchik, ...
Wiley, 2018
Available based on mandate: 4
Amyloid-β peptide Aβ3pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons
AP Gunn, BX Wong, T Johanssen, JC Griffith, CL Masters, AI Bush, ...
Journal of Biological Chemistry 291 (12), 6134-6145, 2016
The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing
A Tsatsanis, AN McCorkindale, BX Wong, E Patrick, TM Ryan, RW Evans, ...
Molecular psychiatry 26 (10), 5516-5531, 2021
Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology
I Diouf, AI Bush, S Ayton, Alzheimer's disease Neuroimaging Initiative
Neurobiology of disease 139, 104810, 2020
CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers
S Ayton, S Janelidze, P Kalinowski, S Palmqvist, AA Belaidi, E Stomrud, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (3), 211-219, 2023
Publication and funding information is determined automatically by a computer program